Novel Peptides Based on HIV-1 gp120 Sequence with Homology to Chemokines Inhibit HIV Infection in Cell Culture
暂无分享,去创建一个
Ning Zhang | Michele A. Kutzler | Oleg Chertov | Jacek Lubkowski | M. Kutzler | J. Lubkowski | B. Crise | O. Chertov | C. McGrath | T. Rogers | J. Oppenheim | R. Sowder | Xin Chen | Anatoli Malyguine | A. Malyguine | Connor McGrath | Ning Zhang | Bruce J. Crise | Thomas J. Rogers | Joost J. Oppenheim | Xin Chen | Raymond C. Sowder | Amber D. Steele | Earl E. Henderson | E. Henderson | A. Steele
[1] F. Belardelli,et al. HIV-1 gp120 Stimulates the Production of β-Chemokines in Human Peripheral Blood Monocytes Through a CD4-Independent Mechanism1 , 2001, The Journal of Immunology.
[2] M. Baggiolini,et al. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. , 1991, The Journal of biological chemistry.
[3] V. Appay,et al. Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. , 1999, The Journal of biological chemistry.
[4] M. Caterina,et al. A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[5] D J Osguthorpe,et al. Dynamics and conformational energetics of a peptide hormone: vasopressin. , 1985, Science.
[6] Stephen C. Peiper,et al. Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions , 1999, Journal of Virology.
[7] J. Sodroski,et al. HIV-1 Entry and Macrophage Inflammatory Protein-1β-mediated Signaling Are Independent Functions of the Chemokine Receptor CCR5* , 1997, The Journal of Biological Chemistry.
[8] R. Doms,et al. CD4-independent utilization of the CXCR4 chemokine receptor by HIV-1 and HIV-2. , 1998, Journal of reproductive immunology.
[9] T. Rogers,et al. The effect of X4 and R5 HIV-1 on C, C-C, and C-X-C chemokines during the early stages of infection in human PBMCs. , 2002, Virology.
[10] S. Arya,et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.
[11] J. Hoxie,et al. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent , 1997, Journal of virology.
[12] T L Hoffman,et al. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] Dan R. Littman,et al. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4 , 1988, Nature.
[14] S. Harrison,et al. Atomic structure of the ectodomain from HIV-1 gp41 , 1997, Nature.
[15] E. Reinherz,et al. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding , 1989, Nature.
[16] D. Osguthorpe,et al. Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system , 1988, Proteins.
[17] D. Capon,et al. The CD4-gp120 interaction and AIDS pathogenesis. , 1991, Annual review of immunology.
[18] Joseph Sodroski,et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.
[19] A. Garzino-Demo,et al. The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection , 1996, Nature Medicine.
[20] D. Volsky,et al. Induction of Rapid and Extensive β-Chemokine Synthesis in Macrophages by Human Immunodeficiency Virus Type 1 and gp120, Independently of Their Coreceptor Phenotype , 2001, Journal of Virology.
[21] N. Skelton,et al. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. , 1997, Biochemistry.
[22] E. Freed,et al. The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection (*) , 1995, The Journal of Biological Chemistry.
[23] E. Clercq,et al. Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4 , 1997, The Journal of experimental medicine.
[24] R. Doms,et al. CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 , 1996, Cell.
[25] B. Sykes,et al. Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.
[26] O. Yoshie,et al. T-Tropic Human Immunodeficiency Virus Type 1 (HIV-1)-Derived V3 Loop Peptides Directly Bind to CXCR-4 and Inhibit T-Tropic HIV-1 Infection , 1998, Journal of Virology.
[27] Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. , 1990, Disease Markers.
[28] E. De Clercq,et al. Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100. , 2001, Molecular pharmacology.
[29] John W. Mellors,et al. Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences , 1997 .
[30] J. Hoxie,et al. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons , 1997, Current Biology.
[31] D. Grainger,et al. Broad-spectrum chemokine inhibitors (BSCIs) and their anti-inflammatory effects in vivo. , 2003, Biochemical pharmacology.
[32] C. Mackay,et al. Interaction of Chemokine Receptor CCR5 with its Ligands: Multiple Domains for HIV-1 gp120 Binding and a Single Domain for Chemokine Binding , 1997, The Journal of experimental medicine.
[33] Michal Sharon,et al. Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity. , 2003, Structure.
[34] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[35] L. Ratner,et al. Analysis of the Critical Domain in the V3 Loop of Human Immunodeficiency Virus Type 1 gp120 Involved in CCR5 Utilization , 1999, Journal of Virology.
[36] B. Cullen,et al. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.
[37] Chongguang Chen,et al. Selective inactivation of CCR5 and decreased infectivity of R5 HIV‐1 strains mediated by opioid‐induced heterologous desensitization , 2003, Journal of leukocyte biology.
[38] J. Sodroski,et al. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion , 1990, Journal of virology.
[39] D. S. Garrett,et al. High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. , 1994, Science.
[40] G. Clore,et al. Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha. , 2005, Journal of molecular biology.
[41] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[42] A. Maynard,et al. Naturally Occurring CCR5 Extracellular and Transmembrane Domain Variants Affect HIV-1 Co-receptor and Ligand Binding Function* , 1999, The Journal of Biological Chemistry.
[43] H. Rochat,et al. V3 loop-derived peptide SPC3 inhibits infection of CD4- and galactosylceramide- cells by LAV-2/B. , 1999, Journal of Peptide Research.
[44] M. Kemeny,et al. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] Q. Sattentau,et al. Identification of the residues in human CD4 critical for the binding of HIV , 1989, Cell.
[46] William C. Olson,et al. Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5 , 1999, Journal of Virology.
[47] J. Sodroski,et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.
[48] Ying Sun,et al. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. , 1998, Science.
[49] S. Lifson,et al. Energy functions for peptides and proteins. I. Derivation of a consistent force field including the hydrogen bond from amide crystals. , 1974, Journal of the American Chemical Society.